CASCADIAN THERAPEUTICS INC's ticker is CASC and the CUSIP is 14740B606. A total of 78 filers reported holding CASCADIAN THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $9,196,000 | +23.5% | 2,485,272 | +36.5% | 0.60% | +3.1% |
| Q3 2017 | $7,449,000 | +10.1% | 1,821,248 | 0.0% | 0.58% | -32.3% |
| Q2 2017 | $6,766,000 | -10.3% | 1,821,248 | 0.0% | 0.85% | -11.3% |
| Q1 2017 | $7,540,000 | +89.9% | 1,821,248 | +97.7% | 0.96% | +20.1% |
| Q4 2016 | $3,971,000 | – | 921,248 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 53 | $0 | 0.00% |